INmune Bio’s $4.8 Million Common Stock Offering

Sichenzia Ross Ference Carmel represented INmune Bio, Inc. in the offering.INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company, announced approximately $4.8 million registered direct offering…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now